前列腺特异抗原 同义词: APS; KLK2A1; PSA; hK3
圣克鲁斯生物技术
| 小鼠 单克隆（A67-B/E3） | - 免疫组化-石蜡切片; 人类; 1:250; 图 1e
| 圣克鲁斯生物技术前列腺特异抗原抗体（Santa Cruz, sc-7316)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:250 (图 1e). Biomedicines (2021) ncbi |
| 小鼠 单克隆（A67-B/E3） | | 圣克鲁斯生物技术前列腺特异抗原抗体（SantaCruz, sc-7316)被用于被用于免疫印迹在人类样本上 (图 3b). Eur J Pharmacol (2017) ncbi |
| 小鼠 单克隆（A67-B/E3） | | 圣克鲁斯生物技术前列腺特异抗原抗体（santa Cruz, sc-7316)被用于被用于免疫组化在人类样本上浓度为1:500 (图 2). Oncol Lett (2016) ncbi |
| 小鼠 单克隆（A67-B/E3） | | 圣克鲁斯生物技术前列腺特异抗原抗体（Santa Cruz, sc-7316)被用于被用于免疫印迹在人类样本上浓度为1:400 (图 1). PLoS ONE (2016) ncbi |
| 小鼠 单克隆（A67-B/E3） | | 圣克鲁斯生物技术前列腺特异抗原抗体（Santa Cruz, sc-7316)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). elife (2016) ncbi |
| 小鼠 单克隆（A67-B/E3） | | 圣克鲁斯生物技术前列腺特异抗原抗体（Santa Cruz, sc-7316)被用于被用于免疫印迹在人类样本上 (图 2). PLoS ONE (2015) ncbi |
| 小鼠 单克隆（A67-B/E3） | | 圣克鲁斯生物技术前列腺特异抗原抗体（Santa Cruz, SC-7316)被用于被用于免疫印迹在人类样本上 (图 2). Sci Rep (2015) ncbi |
| 小鼠 单克隆（A67-B/E3） | - 免疫组化-石蜡切片; 人类; 1:100; 图 s1
| 圣克鲁斯生物技术前列腺特异抗原抗体（SantaCruz, A67-B/E3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 s1). Clin Cancer Res (2016) ncbi |
| 小鼠 单克隆 | - 免疫组化-石蜡切片; 人类; 1:100; 图 s1
| 圣克鲁斯生物技术前列腺特异抗原抗体（SantaCruz, A67-B/E3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 s1). Clin Cancer Res (2016) ncbi |
| 小鼠 单克隆（A67-B/E3） | | 圣克鲁斯生物技术前列腺特异抗原抗体（Santa Cruz, A67-B/E13)被用于被用于免疫印迹在人类样本上 (图 2f). Oncotarget (2015) ncbi |
| 小鼠 单克隆（A67-B/E3） | | 圣克鲁斯生物技术前列腺特异抗原抗体（Santa Cruz Biotechnology, sc-7316)被用于被用于免疫印迹在人类样本上. Am J Physiol Endocrinol Metab (2011) ncbi |
艾博抗（上海）贸易有限公司
| domestic rabbit 单克隆（EP1588Y） | | 艾博抗（上海）贸易有限公司前列腺特异抗原抗体（Abcam, 76113)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2a). Mol Ther Nucleic Acids (2021) ncbi |
| domestic rabbit 单克隆（EP1588Y） | | 艾博抗（上海）贸易有限公司前列腺特异抗原抗体（Abcam, Ab76113)被用于被用于酶联免疫吸附测定在人类样本上. Analyst (2015) ncbi |
赛默飞世尔
| domestic rabbit 多克隆 | | 赛默飞世尔前列腺特异抗原抗体（Pierce, PA1-38514)被用于. Andrologia (2015) ncbi |
赛信通（上海）生物试剂有限公司
| domestic rabbit 单克隆（D2A8） | | 赛信通（上海）生物试剂有限公司前列腺特异抗原抗体（CST, 5877)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5f). Nat Commun (2021) ncbi |
| domestic rabbit 单克隆（D11E1） | | 赛信通（上海）生物试剂有限公司前列腺特异抗原抗体（Cell Signaling, 2475S)被用于被用于免疫印迹在人类样本上 (图 5b). Cancer Sci (2020) ncbi |
| domestic rabbit 单克隆（D6B1） | | 赛信通（上海）生物试剂有限公司前列腺特异抗原抗体（Cell Signaling, 5365S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5b). Mol Cancer Ther (2019) ncbi |
| domestic rabbit 单克隆（D6B1） | | 赛信通（上海）生物试剂有限公司前列腺特异抗原抗体（Cell Signaling, 5365)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 1e). elife (2019) ncbi |
| domestic rabbit 单克隆（D2A8） | | 赛信通（上海）生物试剂有限公司前列腺特异抗原抗体（Cell Signaling, (5877)被用于被用于免疫沉淀在人类样本上 (图 1f). Oncogene (2018) ncbi |
| domestic rabbit 单克隆（D6B1） | | 赛信通（上海）生物试剂有限公司前列腺特异抗原抗体（Cell Signaling, 5365)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Oncol Lett (2016) ncbi |
| domestic rabbit 单克隆（D6B1） | | 赛信通（上海）生物试剂有限公司前列腺特异抗原抗体（Cell Signaling Technology, 5365)被用于被用于免疫印迹在人类样本上 (图 4b). Cell Cycle (2015) ncbi |
| domestic rabbit 单克隆（D6B1） | | 赛信通（上海）生物试剂有限公司前列腺特异抗原抗体（Cell Signaling, 5365)被用于被用于免疫印迹在人类样本上浓度为1:1000. Cell (2014) ncbi |
丹科医疗器械技术服务（上海）有限公司
| domestic rabbit 多克隆 | | 丹科医疗器械技术服务（上海）有限公司前列腺特异抗原抗体（DAKO, A0562)被用于被用于免疫组化在人类样本上浓度为1 ug/ml (图 s5d). Nat Commun (2021) ncbi |
| domestic rabbit 多克隆 | | 丹科医疗器械技术服务（上海）有限公司前列腺特异抗原抗体（Dako, A0562)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3h). Nat Commun (2020) ncbi |
| 小鼠 单克隆（ER-PR8） | | 丹科医疗器械技术服务（上海）有限公司前列腺特异抗原抗体（Dako, M0750)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2b). Science (2016) ncbi |
| 小鼠 单克隆（ER-PR8） | | 丹科医疗器械技术服务（上海）有限公司前列腺特异抗原抗体（Dako, ER-PR8)被用于被用于免疫组化在人类样本上浓度为1:50 (图 2). Int Braz J Urol (2016) ncbi |
| domestic rabbit 多克隆 | - 免疫组化-石蜡切片; 人类; 1:1000; 图 5d
- 免疫印迹; 人类; 1:20,000; 图 3a
| 丹科医疗器械技术服务（上海）有限公司前列腺特异抗原抗体（Dako, A0562)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 5d) 和 被用于免疫印迹在人类样本上浓度为1:20,000 (图 3a). Oncotarget (2016) ncbi |
| 小鼠 单克隆（ER-PR8） | - 免疫组化-石蜡切片; 人类; 1:4000; 图 st2
| 丹科医疗器械技术服务（上海）有限公司前列腺特异抗原抗体（Dako, ER-PR8)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:4000 (图 st2). Oncotarget (2016) ncbi |
Meridian Life Science
| 小鼠 单克隆（B727M） | | 经络生活科学前列腺特异抗原抗体（Meridian, M66276M)被用于被用于酶联免疫吸附测定在人类样本上. PLoS ONE (2015) ncbi |
| 小鼠 单克隆（B728M） | | 经络生活科学前列腺特异抗原抗体（Meridian, M66280M)被用于被用于酶联免疫吸附测定在人类样本上. PLoS ONE (2015) ncbi |
| 小鼠 单克隆（8A6） | | 经络生活科学前列腺特异抗原抗体（Meridian, M86806M)被用于被用于酶联免疫吸附测定在人类样本上. PLoS ONE (2015) ncbi |
徕卡显微系统(上海)贸易有限公司
| 小鼠 单克隆（35H9） | | 徕卡显微系统(上海)贸易有限公司前列腺特异抗原抗体（Leica, 35H9)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1g). Diagn Cytopathol (2017) ncbi |
| 小鼠 单克隆（35H9） | | 徕卡显微系统(上海)贸易有限公司前列腺特异抗原抗体（Novocastra, NCL-PSA-431)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Virchows Arch (2014) ncbi |
Bamodu O, Wang Y, Yeh C, Ho C, Chiang Y, Kao W,
et al. Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer. Biomedicines. 2021;9:
pubmed 出版商 Goel S, Bhatia V, Kundu S, Biswas T, Carskadon S, Gupta N,
et al. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression. Nat Commun. 2021;12:5325
pubmed 出版商 Risbridger G, Clark A, Porter L, Toivanen R, Bakshi A, Lister N,
et al. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology. Nat Commun. 2021;12:5049
pubmed 出版商 Corbin J, Georgescu C, Wren J, Xu C, Asch A, Ruiz Echevarría M. Seed-mediated RNA interference of androgen signaling and survival networks induces cell death in prostate cancer cells. Mol Ther Nucleic Acids. 2021;24:337-351
pubmed 出版商 Vatapalli R, Sagar V, Rodriguez Y, Zhao J, Unno K, Pamarthy S,
et al. Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. Nat Commun. 2020;11:4153
pubmed 出版商 Zhao J, Zhang Y, Liu X, Zhu F, Xie F, Jiang C,
et al. RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression. Cancer Sci. 2020;111:369-382
pubmed 出版商 Mao N, Gao D, Hu W, Hieronymus H, Wang S, Lee Y,
et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18:1577-1586
pubmed 出版商 Lee E, Wongvipat J, Choi D, Wang P, Lee Y, Zheng D,
et al. GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance. elife. 2019;8:
pubmed 出版商 Li N, Truong S, Nouri M, Moore J, Al Nakouzi N, Lubik A,
et al. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3. Oncogene. 2018;37:2313-2325
pubmed 出版商 Jia L, Jiang Y, Michael C. Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma. Diagn Cytopathol. 2017;45:998-1004
pubmed 出版商 Hennenberg M, Tamalunas A, Wang Y, Keller P, Schott M, Strittmatter F,
et al. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region. Eur J Pharmacol. 2017;803:39-47
pubmed 出版商 Fang F, Qin Y, Hao F, Li Q, Zhang W, Zhao C,
et al. CD147 modulates androgen receptor activity through the Akt/Gsk-3?/?-catenin/AR pathway in prostate cancer cells. Oncol Lett. 2016;12:1124-1128
pubmed Sui X, Hu Y, Zhang C, Pan H, Li D. Prostate cancer metastasis to the distal phalanx of the left hallux: The first confirmed case and literature review. Oncol Lett. 2016;12:1074-1078
pubmed Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate Shen C. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352:1576-80
pubmed 出版商 Arista Nasr J, Martinez Benitez B, Bornstein Quevedo L, Aguilar Ayala E, Aleman Sanchez C, Ortiz Bautista R. Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy. Int Braz J Urol. 2016;42:247-52
pubmed 出版商 Wang Y, Gratzke C, Tamalunas A, Wiemer N, Ciotkowska A, Rutz B,
et al. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate. PLoS ONE. 2016;11:e0153312
pubmed 出版商 Wu J, Ivanov A, Fisher P, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. elife. 2016;5:
pubmed 出版商 Destouches D, Sader M, Terry S, Marchand C, Maillé P, Soyeux P,
et al. Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer. Oncotarget. 2016;7:69397-69411
pubmed 出版商 Meller S, Meyer H, Bethan B, Dietrich D, Maldonado S, Lein M,
et al. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer. Oncotarget. 2016;7:1421-38
pubmed 出版商 Guo J, Huang X, Wang H, Yang H. Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells. PLoS ONE. 2015;10:e0140745
pubmed 出版商 Jokerst J, Chen Z, Xu L, Nolley R, Chang E, Mitchell B,
et al. A Magnetic Bead-Based Sensor for the Quantification of Multiple Prostate Cancer Biomarkers. PLoS ONE. 2015;10:e0139484
pubmed 出版商 Xu S, Wang T, Song W, Jiang T, Zhang F, Yin Y,
et al. The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism. Sci Rep. 2015;5:13528
pubmed 出版商 Leclerc B, Charlebois R, Chouinard G, Allard B, Pommey S, Saad F,
et al. CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer. Clin Cancer Res. 2016;22:158-66
pubmed 出版商 Liu X, Chen X, Rycaj K, Chao H, Deng Q, Jeter C,
et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 2015;6:23959-86
pubmed Madaboosi N, Soares R, Chu V, Conde J. A microfluidic immunoassay platform for the detection of free prostate specific antigen: a systematic and quantitative approach. Analyst. 2015;140:4423-33
pubmed 出版商 Zhang Z, Chen L, Wang H, Ahmad N, Liu X. Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer. Cell Cycle. 2015;14:2142-8
pubmed 出版商 Gao D, Vela I, Sboner A, Iaquinta P, Karthaus W, Gopalan A,
et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176-187
pubmed 出版商 Seipel A, Samaratunga H, Delahunt B, Wiklund F, Wiklund P, Lindberg J,
et al. Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Arch. 2014;465:559-65
pubmed 出版商 Lokant M, Naz R. Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis). Andrologia. 2015;47:328-32
pubmed 出版商 Hsu F, Yang M, Lin E, Tseng C, Lin H. The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. Am J Physiol Endocrinol Metab. 2011;300:E902-8
pubmed 出版商
